CLEVELAND, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today ...

(MENAFN- GlobeNewsWire - Nasdaq) CLEVELAND, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies ...

CLEVELAND - Abeona Therapeutics Inc. (NASDAQ:ABEO) ha nombrado a James A. Gow, MD, como Vicepresidente Senior, Jefe de Desarrollo Clínico y Asuntos Médicos, con efecto inmediato, anunció el lunes la ...

CLEVELAND, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today ...

CLEVELAND - Abeona Therapeutics Inc. (NASDAQ:ABEO) has appointed James A. Gow, MD, as Senior Vice President, Head of Clinical Development & Medical Affairs, effective immediately, the company ...

CLEVELAND - Abeona Therapeutics Inc. (NASDAQ:ABEO) has appointed James A. Gow, MD, as Senior Vice President, Head of Clinical Development & Medical Affairs, effective immediately, the commercial-stage ...

(MENAFN- Adfactors PR) 9thJuly 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its ...

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Bromfenac Ophthalmic Solution. The drug belongs ...

Bausch + Lomb, empresa líder en salud ocular, registró un sólido cierre del ejercicio 2023 con unos ingresos en el cuarto trimestre de 1.173 millones de dólares, lo que supone un aumento interanual ...

Lupin has received the Food and Drug Administration’s permission for a new generic, and the company has launched two new generics. The company has received the FDA's blessing for Propranolol ...